13.08.2020 • NewsBraskemOdebrecht

Odebrecht Starts Braskem Sale

Brazilian conglomerate Odebrecht has begun the initial process to sell up to its full shareholding in polyolefins producer Braskem. Odebrecht is selling its stake in order to fulfil commitments it made to creditors, both before and during its bankruptcy, Braskem said.

A Brazilian judge on Jul. 27 approved Odebrecht’s restructuring plans, rejecting objections from creditors. Odebrecht filed for bankruptcy protection in June 2019 in order to restructure $13 billion of debt after its involvement in Brazil’s “car wash” money laundering scandal that emerged in 2014.

Odebrect owns 38.3% of Braskem’s outstanding shares and 50.1% of its voting shares, while Brazilian state-energy producer Petrobras holds 36.1% of outstanding shares and 47% of voting shares.

Petrobras said last December that it wanted to sell its Braskem stake within the next 12 months. Last month, the company was said to be within six months of reaching a consensus with Odebrecht on a new shareholder agreement for Braskem, which will see preferred shares converted to a single class of common shares, facilitating a sale.

LyondellBasell was in talks with Odebrecht earlier last year about buying Braskem but the companies called a halt to negotiations in June 2019.

 

Author: Elaine Burridge, Freelance Journalist

Braskem has started up a 450,000 t/y PP plant in LaPorte, Texas, USA. The...
Braskem has started up a 450,000 t/y PP plant in LaPorte, Texas, USA. The facility, named Delta, produces a variety of grades, including homopolymers, impact copolymers and random copolymers. The company is also building a global PP export center in Charleston, South Carolina. (c) Braskem

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.